Khepri Pharmaceuticals Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $33.4M

Khepri Pharmaceuticals General Information

Description

Developer of therapeutic products based on proteases and protease inhibitors. The company is a biopharmaceutical company which developes proteases and their inhibitors as therapeutics.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 385 Oyster Point Boulevard
  • Suite 3
  • South San Francisco, CA 94080
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 385 Oyster Point Boulevard
  • Suite 3
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Khepri Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 26-Dec-1995 $33.4M Completed Product Development
3. Early Stage VC 10-Nov-1994 Completed Product Development
2. Early Stage VC 08-Jan-1993 $6.8M $11.8M Completed Product Development
1. Early Stage VC 01-Jan-1994 $5M $5M Completed Product Development
To view Khepri Pharmaceuticals’s complete valuation and funding history, request access »

Khepri Pharmaceuticals Patents

Khepri Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-1996013523-A1 Cathepsin o2 protease Inactive 27-Oct-1994
US-20030175937-A1 Proteins; nucleic acid; antibodies; bone remodeling Inactive 27-Oct-1994
WO-1995023222-A1 Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups Inactive 25-Feb-1994 C07D295/215

Khepri Pharmaceuticals Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Brentwood Associates PE/Buyout Minority
CHL Medical Partners Venture Capital Minority
Genentech Corporation Minority
Kleiner Perkins Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Khepri Pharmaceuticals FAQs

  • When was Khepri Pharmaceuticals founded?

    Khepri Pharmaceuticals was founded in 1992.

  • Where is Khepri Pharmaceuticals headquartered?

    Khepri Pharmaceuticals is headquartered in South San Francisco, CA.

  • What industry is Khepri Pharmaceuticals in?

    Khepri Pharmaceuticals’s primary industry is Biotechnology.

  • Is Khepri Pharmaceuticals a private or public company?

    Khepri Pharmaceuticals is a Private company.

  • What is the current valuation of Khepri Pharmaceuticals?

    The current valuation of Khepri Pharmaceuticals is .

  • What is Khepri Pharmaceuticals’s current revenue?

    The current revenue for Khepri Pharmaceuticals is .

  • How much funding has Khepri Pharmaceuticals raised over time?

    Khepri Pharmaceuticals has raised $22.8M.

  • Who are Khepri Pharmaceuticals’s investors?

    Abingworth, Brentwood Associates, CHL Medical Partners, Genentech, and Kleiner Perkins are 5 of 12 investors who have invested in Khepri Pharmaceuticals.

  • When was Khepri Pharmaceuticals acquired?

    Khepri Pharmaceuticals was acquired on 26-Dec-1995.

  • Who acquired Khepri Pharmaceuticals?

    Khepri Pharmaceuticals was acquired by AXYS Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process